Turnover
≈ €63,000 estimated
The micro format states no turnover.
EMBRYOLUX
Lifetime
3 annual accounts with figures on one time axispeak €16,817 (2025)
€16,817▲ 34.8%
lowest -€6,269 (2023)
€10,799▲ 14.5%
peak €43,961 (2025)
€43,961▲ 32.6%
€26,664▲ 16.3%
Board3 names since 2023
3 directors and 2 others
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €12,477 to €16,817Equity from €33,163 to €43,961Debts from €22,932 to €26,664Cash from €6,998 to €2,800
Key points
from the 2025 annual accountsFilings
3 annual accounts 3 late
The 2023 accounts came latest: 71 days after the end of the period.
Starting capital
€30,000 300 shares
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,274 companies had the same profile as EMBRYOLUX has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for EMBRYOLUX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 16-05-2023
Director, since 16-05-2023
Director, since 16-05-2023
- 100 sharesdeed of 22-05-2023
- 100 sharesdeed of 22-05-2023
- 100 sharesdeed of 22-05-2023
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0801869405
Incorporation
Founding capital of €30,000, 300 shares · Appointments: , and · Registered office clause: Chemin de Martelange 6C, 6640 Vaux-sur-Sûre · published on 22-05-2023 · Gazette deed
First establishment
Chemin de Martelange,Cobreville 6, Vaux-sur-Sûre
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| EMBRYOLUX Vaux-sur-Sûre | €70,625 | €16,817 | 62.2% | - |
| Nick Moyaert Schilde | €59,510 | €19,083 | 93.5% | - |
| H for Horse Chaumont-Gistoux | €101,073 | €15,504 | 4.9% | - |
| GVH Horses Shoes Meise | €82,051 | €13,847 | 34.4% | - |
| David Piqué Horebeke | €47,719 | €13,519 | 11.5% | - |
| B-trout Beernem | €79,710 | €19,131 | 43.6% | - |
| HOEFSMID BRAM VERTRIEST Dentergem | €132,882 | €18,733 | 13.6% | - |
These companies have the same main activity as EMBRYOLUX: support activities for animal production (NACE 01620). They are comparable in size and age: total assets between €47,700 and €133,000, founded between 2020 and 2024.
Official details
Source: KBO- Status
- Active since 17-05-2023Normal situation
- Activity
- Support activities for animal productionNACE 01620
- Establishment unit
- 2.350.427.1906640 Vaux-sur-Sûre, since 17-05-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 23-07-2025
Insights on EMBRYOLUX
EMBRYOLUX files the micro format. That format states no turnover. The gross margin rose from -€5,523 in 2023 to €16,817 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about EMBRYOLUX
- What is the company number of EMBRYOLUX?
- The company number of EMBRYOLUX is 0801.869.405. The VAT number is the same number with BE in front: BE 0801.869.405.
- Where is EMBRYOLUX based?
- The registered office is at Chemin de Martelange,Cobreville 6, 6640 Vaux-sur-Sûre.Company details
- What does EMBRYOLUX do?
- According to the KBO register, the main activity is support activities for animal production (NACE 01620).
- What is the legal form of EMBRYOLUX?
- EMBRYOLUX is a private limited company (BV).
- When was EMBRYOLUX founded?
- EMBRYOLUX was founded on 17-05-2023.
- Is EMBRYOLUX still active?
- Yes, EMBRYOLUX is an active enterprise in the KBO register.
- What is the turnover of EMBRYOLUX?
- The turnover in financial year 2025 is ≈ €63,000. This figure is estimated from the gross margin of €16,817 and 33 comparable companies (NACE 01). It probably lies between €30,000 and €140,000. It is a rough estimate.Financials
- Is EMBRYOLUX profitable?
- In financial year 2025, EMBRYOLUX made a profit of €10,799.
- Where can I find the annual accounts of EMBRYOLUX?
- EMBRYOLUX filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of EMBRYOLUX due?
- EMBRYOLUX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.